Oxygen Therapy Market Size, Share & Trends Analysis Report By Product (Oxygen Source Equipment, Oxygen Delivery Devices), By Application, By End-use, By Region, And Segment Forecasts, 2022 - 2030

Oxygen Therapy Market Growth & Trends

The global oxygen therapy market size is expected to reach USD 40.1 billion by 2030, registering a CAGR of 10.4% during the forecast period, according to a new report by Grand View Research, Inc. The increasing prevalence of major respiratory diseases, such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and obstructive sleep apnea, is a high-impact rendering driver of the market. According to WHO, a global rise in the prevalence of asthma and other respiratory disorders is expected to enhance clinical urgency to treat these conditions and is expected to boost the demand for O2 therapy as the first-line treatment and as a supplement in various applications.

Moreover, technological advancements are anticipated to provide growth platforms in a wide range of new applications such as cancer and diabetes; for instance, the incorporation of flow sensors in delivery devices to conserve & regulate the flow enables greater patient comfort and outcomes. Furthermore, the increasing focus on home healthcare solutions coupled with the development of portable delivery devices has a major impact on the market. These factors are expected to significantly contribute to the market growth during the forecast period.

The COVID-19 pandemic has positively impacted the market for O2 therapy devices. Due to the outbreak, the demand for oxygen significantly increased, especially when the number of patients suffering from COVID-19 increased in hospitals. Moreover, pressure on oxygen supplies in hospitals has been caused by a large number of COVID-19 patients. Therefore, the demand for O2 therapy devices in the healthcare sector has increased and is expected to continue to increase significantly in the near future. Governments of various countries are focusing on expanding healthcare facilities in rural areas. With upcoming infrastructural projects, the demand for medical O2 is expected to substantially increase.

Oxygen Therapy Market Report Highlights

  • The oxygen source equipment segment dominated the product segment in terms of revenue share in 2021 owing to its high usage rate and wide-scale availability in various forms such as liquid compressed gas and concentrators
  • On the other hand, oxygen delivery devices are expected to grow at a lucrative rate as they are an indispensable part of oxygen therapy set-ups, thereby contributing to the overall market growth during the forecast period
  • Oxygen concentrators spearheaded the source equipment market segment owing to the rising popularity and adoption of portable concentrators in emergency medicine, ambulatory, and home settings
  • Oxygen masks dominated the delivery devices market segment in 2021, as a consequence of being an indispensable unit of the delivery system and greater availability of specialty masks as per a patient’s physiological needs
  • Chronic Obstructive Pulmonary Disease (COPD) held a substantial market share of the application segment and accounted for over 38.0% of the overall revenue share, owing to the presence of unmet needs for COPD treatment, thereby boosting the market demand
  • Home healthcare is anticipated to grow lucratively owing to associated benefits such as long-term cost-effectiveness and increased mobility, which is expected to propel the demand during the forecast period
  • Moreover, the presence of organizations, such as the American Association for Homecare, to promote awareness and strengthen home healthcare is expected to provide growth opportunities in the market
  • Market players are adopting strategies, such as new product development, technological innovation, and strategic collaborations, such as mergers & acquisitions, to increase their industry share
Please note The report will be delivered in 4-8 business days upon order notification.


Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Regional Scope
1.1.3 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.3.5.1 Data for Primary Interviews in North America
1.3.5.2 Data for Primary Interviews in Europe
1.3.5.3 Data for Primary Interviews in Asia Pacific
1.3.5.4 Data for Primary Interviews in Latin America
1.3.5.5 Data for Primary Interviews in MEA
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 Objectives
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
Chapter 3 Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Regulatory Framework
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.2 Market Restraint Analysis
3.4.3 Industry Challenges
3.5 .Oxygen Therapy Market Analysis Tools
3.5.1 Industry Analysis - Porter’s
3.5.1.1 Supplier Power
3.5.1.2 Buyer Power
3.5.1.3 Substitution Threat
3.5.1.4 Threat From New Entrant
3.5.1.5 Competitive Rivalry
3.5.2 PESTEL Analysis
3.5.2.1 Political Landscape
3.5.2.2 Technological Landscape
3.5.2.3 Economic Landscape
3.5.3 Technology Trend Analysis
3.5.3.1 Changing Technology & Adoption Pattern
Chapter 4 COVID-19 Impact Analysis
4.1 Current and Future Impact Analysis
4.2 Recent Developments By Market Players
Chapter 5 Oxygen Therapy Market: Competitive Analysis
5.1 Market Participation Categorization
5.2 Public Companies
5.2.1 Estimated Company Market Share/Position Analysis, 2021
5.2.2 Major Deals & Strategic Alliances Analysis
5.3 Private Companies
5.3.1 Detailed List of Market Players
5.4 Market Entry Strategies
Chapter 6 Oxygen Therapy Market: Product Segment Analysis
6.1 Oxygen Therapy Market Share, By Product, 2017 & 2030
6.2 Oxygen Source Equipment
6.2.1 Oxygen Source Equipment Market, 2017 - 2030 (USD Million)
6.2.2 Oxygen Cylinders
6.2.2.1 Oxygen Cylinders Market, 2017 - 2030 (USD Million)
6.2.3 Oxygen Concentrators
6.2.3.1 Oxygen Concentrators Market, 2017 - 2030 (USD Million)
6.2.4 Liquid Oxygen Devices
6.2.4.1 Liquid Oxygen Devices Market, 2017 - 2030 (USD Million)
6.2.5 PAP Devices
6.2.5.1 PAP Devices Market, 2017 - 2030 (USD Million)
6.3 Oxygen Delivery Devices
6.3.1 Oxygen Delivery Devices Market, 2017 - 2030 (USD Million)
6.3.2 Oxygen Masks
6.3.2.1 Oxygen Masks Market, 2017 - 2030 (USD Million)
6.3.3 Nasal Cannula
6.3.3.1 Nasal Cannula Market, 2017 - 2030 (USD Million)
6.3.4 Venturi Masks
6.3.4.1 Venturi Masks Market, 2017 - 2030 (USD Million)
6.3.5 Non-rebreather Masks
6.3.5.1 Non-rebreather Masks Market, 2017 - 2030 (USD Million)
6.3.6 Bag Valve Masks
6.3.6.1 Bag Valve Masks Market, 2017 - 2030 (USD Million)
6.3.7 CPAP Masks
6.3.7.1 CPAP Masks Market, 2017 - 2030 (USD Million)
6.3.8 Others
6.3.8.1 Others Market, 2017 - 2030 (USD Million)
Chapter 7 Oxygen Therapy Market: Application Segment Analysis
7.1 Oxygen Therapy Market: Application Movement Analysis
7.2 Global Oxygen Therapy Market Share, By Application, 2017 & 2030
7.3 Chronic Obstructive Pulmonary Disease
7.3.1 Chronic Obstructive Pulmonary Disease Market, 2017 - 2030 (USD Million)
7.3.2 Asthma
7.3.2.1 Asthma Market, 2017 - 2030 (USD Million)
7.3.3 Obstructive Sleep Apnea
7.3.3.1 Obstructive Sleep Apnea Market, 2017 - 2030 (USD Million)
7.3.4 Respiratory Distress Syndrome
7.3.4.1 Respiratory Distress Syndrome Market, 2017 - 2030 (USD Million)
7.3.5 Cystic Fibrosis
7.3.5.1 Cystic Fibrosis Market, 2017 - 2030 (USD Million)
7.3.6 Pneumonia
7.3.6.1 Pneumonia Market, 2017 - 2030 (USD Million)
7.3.7 Others
7.3.7.1 Others Market, 2017 - 2030 (USD Million)
Chapter 8 Oxygen Therapy Market: End-use Segment Analysis
8.1 Oxygen Therapy Market: End-use Movement Analysis
8.2 Hospital
8.2.1 Hospital Market, 2017 - 2030 (USD Million)
8.3 Home Healthcare
8.3.1 Home Healthcare Market, 2017 - 2030 (USD Million)
Chapter 9 Oxygen Therapy Market: Regional Estimates & Trend Analysis, By Product, Application, End-use
9.1 Oxygen Therapy Market Share By Region, 2021 & 2030
9.2 Regional Dashboard Analysis
9.3 North America
9.3.1 North America Oxygen Therapy Market, 2017 - 2030 (USD Million)
9.3.2 U.S.
9.3.2.1 U.S. Oxygen Therapy Market, 2017 - 2030 (USD Million)
9.3.3 Canada
9.3.3.1 Canada Oxygen Therapy Market, 2017 - 2030 (USD Million)
9.4 Europe
9.4.1 Europe Oxygen Therapy Market, 2017 - 2030 (USD Million)
9.4.2 Germany
9.4.2.1 Germany Oxygen Therapy Market, 2017 - 2030 (USD Million)
9.4.3 U.K.
9.4.3.1 U.K. Oxygen Therapy Market, 2017 - 2030 (USD Million)
9.4.4 France
9.4.4.1 France Oxygen Therapy Market, 2017 - 2030 (USD Million)
9.4.5 Italy
9.4.5.1 Italy Oxygen Therapy Market, 2017 - 2030 (USD Million)
9.4.6 Spain
9.4.6.1 Spain Oxygen Therapy Market, 2017 - 2030 (USD Million)
9.5 Asia Pacific
9.5.1 Asia Pacific Oxygen Therapy Market, 2017 - 2030 (USD Million)
9.5.2 Japan
9.5.2.1 Japan Oxygen Therapy Market, 2017 - 2030 (USD Million)
9.5.3 China
9.5.3.1 China Oxygen Therapy Market, 2017 - 2030 (USD Million)
9.5.4 India
9.5.4.1 India Oxygen Therapy Market, 2017 - 2030 (USD Million)
9.6 Latin America
9.6.1 Latin America Oxygen Therapy Market, 2017 - 2030 (USD Million)
9.6.2 Brazil
9.6.2.1 Brazil Oxygen Therapy Market, 2017 - 2030 (USD Million)
9.6.3 Mexico
9.6.3.1 Mexico Oxygen Therapy Market, 2017 - 2030 (USD Million)
9.7 MEA
9.7.1 MEA Oxygen Therapy Market, 2017 - 2030 (USD Million)
9.7.2 South Africa
9.7.2.1 South Africa Oxygen Therapy Market, 2017 - 2030 (USD Million)
9.7.3 Saudi Arabia
9.7.3.1 Saudi Arabia Oxygen Therapy Market, 2017 - 2030 (USD Million)
Chapter 10 Oxygen Therapy Market: Company Profiles
10.1 Koninklijke Philips N.V. Corporation
10.1.1 Company Overview
10.1.2 Financial Performance
10.1.3 Product Benchmarking
10.1.4 Strategic Initiatives
10.2 General Electric Company
10.2.1 Company Overview
10.2.2 Financial Performance
10.2.3 Product Benchmarking
10.2.4 Strategic Initiatives
10.3 Linde plc
10.3.1 Company Overview
10.3.2 Financial Performance
10.3.3 Product Benchmarking
10.3.4 Strategic Initiatives
10.4 Chart Industries
10.4.1 Company Overview
10.4.2 Financial Performance
10.4.3 Product Benchmarking
10.4.4 Strategic Initiatives
10.5 BD
10.5.1 Company Overview
10.5.2 Financial Performance
10.5.3 Product Benchmarking
10.5.4 Strategic Initiatives
10.6 ICU Medical
10.6.1 Company Overview
10.6.2 Financial Performance
10.6.3 Product Benchmarking
10.6.4 Strategic Initiatives
10.7 HERSILL
10.7.1 Company Overview
10.7.2 Financial Performance
10.7.3 Product Benchmarking
10.7.4 Strategic Initiatives
10.8 Fisher & Paykel Healthcare Limited
10.8.1 Company Overview
10.8.2 Financial Performance
10.8.3 Product Benchmarking
10.8.4 Strategic Initiatives
10.9 Allied Healthcare Products, Inc.
10.9.1 Company Overview
10.9.2 Financial Performance
10.9.3 Product Benchmarking
10.9.4 Strategic Initiatives
10.10 Tecno-Gaz SpA
10.10.1 Company Overview
10.10.2 Financial Performance
10.10.3 Product Benchmarking
10.10.4 Strategic Initiatives
10.11 Teleflex Incorporated
10.11.1 Company Overview
10.11.2 Financial Performance
10.11.3 Product Benchmarking
10.11.4 Strategic Initiatives
10.12 DeVilbiss Healthcare LLC
10.12.1 Company Overview
10.12.2 Financial Performance
10.12.3 Product Benchmarking
10.12.4 Strategic Initiatives
10.13 Getinge AB
10.13.1 Company Overview
10.13.2 Financial Performance
10.13.3 Product Benchmarking
10.13.4 Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings